Kura Oncology
John Wang currently serves as the Executive Director of Commercial Operations at Kura Oncology, Inc., since March 2025. Prior to this role, John held various positions in analytics and commercial operations, including Senior Director of Analytics & Insights at Jazz Pharmaceuticals from October 2020 to March 2025, and Senior Director, Commercial Operations Lead at Adamas Pharmaceuticals, Inc. from October 2019 to October 2020. John’s background includes significant experience at Amgen, where responsibilities spanned directing US Oncology, Commercial Strategy & Analytics and managing teams focused on hematology with oversight of multiple disease areas. Additionally, John contributed at Campbell Alliance as an Engagement Manager and Consultant from October 2009 to March 2013. Academic qualifications include a Master of Business Administration from the Rotman School of Management at the University of Toronto and a Master in Biochemistry from the University of Toronto.
This person is not in any teams
This person is not in any offices
Kura Oncology
20 followers
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment.